JR Precious, former Finance Director 1990-1994

Interviewee joined company in 1990 as Finance Director and left in 1994.

Pages 1-41 only of 47 are available. Pages 42-47 have been catalogued separately in WF/M/AV/O/02/50a and closed. Topics discussed include:

* impressions of company, and lengthy assessment of it

* corporate atmosphere

* effects of the flotation an changes within company

* research costs and management

* provision of financial information

* relationship between UK and US companies

* Retrovir, issues over pricing and marketing, public relations/ customer relations, Concorde Study

* Japan market

* Calmic, Wellcome Environmental Health, Wellcome Diagnostic

* relationship between WT and company

* potential merger with Zeneca

* share price and merger with Glaxo

17 Nov 2001

audio tape and transcript Tape 53

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.